Commit To Purchase Recro Pharma At $10, Earn 17.8% Annualized Using Options
September 06, 2019 at 11:19 AM EDT
Investors eyeing a purchase of Recro Pharma, Inc (REPH) stock, but tentative about paying the going market price of $11.87/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2020 put at the $10 strike, which has a bid at the time of this writing of 65 cents..